Fresenius Medical Care provides an overview of the analysts’ recommendations and the consensus estimates.
In our analysis of the shareholder structure as of December 31, 2024, approximately 92% of the free float could be attributed to their respective owners. Accordingly, the largest shareholder was Fresenius SE & Co. KGaA, holding approximately 94.4 M of the total approximately 293.4 M outstanding Fresenius Medical Care shares. This corresponds to a stake of 32.2%. Additionally, 9 institutional investors were identified as holding at least 1% of the share capital.
554 institutional investors hold shares of Fresenius Medical Care according to the latest analysis. The largest 20 of them account for approximately 63.0% of the identified free float, excluding the stake of Fresenius SE & Co. KGaA (previous year: 66.0%).
72.2% of the institutional free float as of December 31, 2024, was held by investors from the United States and Canada. 8.8% were from the United Kingdom. 5.8% of the institutional free float could be identified in Germany, and an additional 3.8% was held by investors in France.
Number of shares in M | Number of shares in % | |
---|---|---|
Identified shares | 277.5 | 95 |
Unidentified shares | 15.9 | 5 |
Number of shares outstanding | 293.4 | 100 |
Identified shares in free float | 183 | 92 |
Unidentified shares in free float | 16 | 8 |
Shares in free float | 199.0 | 67.8 |
Shares in free float | 199.0 | 67.8 |
Fresenius SE & Co. KGaA | 94.4 | 32.2 |
Number of shares outstanding | 293.4 | 100 |